Analyte meter including an RFID reader

Patent metadata

Field	Value
Publication number	US-9907470-B2
Application number	US-201615136310-A
Country	US
Kind code	B2
Filing date	Apr 22, 2016
Priority date	Feb 8, 2005
Publication date	Mar 6, 2018
Grant date	Mar 6, 2018

Abstract

A glucose monitoring system, includes a glucose sensor strip or package of strips. The strip includes a substrate and a glucose monitoring circuit that has electrodes and a bodily fluid application portion of selected chemical composition. An antenna is integrated with the glucose sensor strip. A RFID sensor chip is coupled with the glucose sensor strip and the antenna. The chip has a memory containing digitally-encoded data representing calibration and/or expiration date information for the strip.

First claim

What is claimed is:

1. An analyte monitoring system for use in diabetes management, comprising:
a radio frequency identification (RFID) reader that transmits a first radio wave and receives a second radio wave; and
an analyte sensing device, comprising:
a partially or fully implantable in vivo analyte sensor configured to provide one or more signals indicative of an analyte level in a sample; and
an RFID sensor comprising a memory in which the one or more signals indicative of the analyte level is digitally encoded and stored therein,
wherein the RFID sensor receives the first radio wave from the RFID reader and, after receipt of the first radio wave, transmits the digitally encoded signals indicative of the analyte level in the second radio wave to the RFID reader, and
wherein the RFID reader reads the digitally encoded signals indicative of the analyte level in the second radio wave received from the RFID sensor.

2. The analyte monitoring system of claim 1 , wherein the RFID sensor is a passive RFID sensor.

3. The analyte monitoring system of claim 2 , wherein the first radio wave is an interrogation signal and the second radio wave is a backscattered radio wave, and wherein the RFID sensor transmits the second radio wave in response to impingement of the first radio wave on an antenna of the RFID sensor.

4. The analyte monitoring system of claim 2 , wherein the RFID sensor uses power from the first radio wave.

5. The analyte monitoring system of claim 2 , wherein the passive RFID sensor does not comprise a battery.

6. The analyte monitoring system of claim 1 , wherein the RFID sensor is an active RFID sensor.

7. The analyte monitoring system of claim 1 , wherein the RFID sensor is part of an RFID tag.

8. The analyte monitoring system of claim 1 , wherein the RFID sensor is a chip mounted on a PCB substrate.

9. The analyte monitoring system of claim 1 , wherein the RFID sensor comprises a transponder that receives the first radio wave and transmits the second radio wave, containing the diabetes information, after receipt of the first radio wave.

10. The analyte monitoring system of claim 1 , wherein the diabetes information is calibration information, expiration information, data representing a lot number, data representing a manufacture date, or data representing a sensor type.

11. The analyte monitoring system of claim 1 , wherein the analyte sensing device comprises an antenna.

12. The analyte monitoring system of claim 11 , wherein the antenna is a loop antenna.

13. The analyte monitoring system of claim 11 , wherein the antenna is a dipole antenna.

14. The analyte monitoring system of claim 11 , wherein the antenna is integrated with the in vivo analyte sensor.

15. The analyte monitoring system of claim 14 , wherein the in vivo analyte sensor comprises a substrate, and wherein the antenna comprises a conducting loop extending around substantially a perimeter of the substrate and has two ends coupled with the RFID sensor.

16. The analyte monitoring system of claim 1 , wherein the in vivo analyte sensor comprises a plurality of electrodes that include a working electrode and a counter electrode.

17. The analyte monitoring system of claim 16 , wherein the plurality of electrodes includes a reference electrode.

18. The analyte monitoring system of claim 16 , wherein the in vivo analyte sensor comprises an analyte monitoring circuit having the plurality of electrodes and a bodily fluid application portion.

19. The analyte monitoring system of claim 1 , wherein the analyte sensing device performs electrolysis on a bodily fluid.

20. The analyte monitoring system of claim 1 , wherein the RFID reader comprises a pump.

21. The analyte monitoring system of claim 1 , wherein the RFID reader comprises a housing with a display and one or more operational buttons.

22. The analyte monitoring system of claim 1 , wherein the RFID reader comprises a transceiver and an antenna.

23. The analyte monitoring system of claim 22 , wherein the RFID reader further comprises a directional coupler that couples the transceiver to the antenna.

24. The analyte monitoring system of claim 22 , wherein the transceiver and antenna of the RFID reader supply power to the RFID sensor with the first radio wave.

25. The analyte monitoring system of claim 1 , wherein the RFID reader has processing capability and reads the digitally encoded signals indicative of the analyte level from the second radio wave and uses the digitally encoded signals to determine an analyte level of a bodily fluid.

26. The analyte monitoring system of claim 1 , wherein the RFID reader transmits a third radio wave to the RFID sensor, the third radio wave including information to be written to the RFID sensor.

27. The analyte monitoring system of claim 1 , wherein the RFID reader is capable of programming the RFID sensor.

28. The analyte monitoring system of claim 1 , wherein the RFID reader further comprises an analyte meter and a test strip port.

29. The analyte monitoring system of claim 28 , further comprising circuitry for determining the analyte level of a bodily fluid sample on a test strip inserted into the port.

30. The analyte monitoring system of claim 1 , wherein the RFID reader is integrated with an analyte meter.

31. The analyte monitoring system of claim 1 , further comprising a modular analyte meter.

32. The analyte monitoring system of claim 1 , wherein the RFID reader communicates data with an analyte meter by way of a cable, multi-pin connection, or wireless connection.

33. The analyte monitoring system of claim 1 , wherein the RFID reader shares processing capability with an analyte meter.

34. The analyte monitoring system of claim 1 , wherein the RFID reader shares memory with an analyte meter.

35. The analyte monitoring system of claim 1 , wherein the RFID reader is a component of another device.

36. The analyte monitoring system of claim 1 , wherein the analyte is glucose.

37. The analyte monitoring system of claim 1 , wherein the first radio wave is in a frequency band around 13.56 MHz.

38. The analyte monitoring system of claim 1 , wherein the first radio wave is in a frequency band around 2.45 GHz.

Assignees

• Abbott Diabetes Care Inc

Inventors

• Goodnow Timothy T
• He Lei Lawrence

Classifications

• A61B5/1495

  Calibrating or testing of in-vivo probes · CPC title

• G08C17/02

  using a radio link · CPC title

• A61B5/1486 Primary

  using enzyme electrodes, e.g. with immobilised oxidase · CPC title

• A61B5/150358

  Strips for collecting blood, e.g. absorbent · CPC title

• A61B5/7282

  Event detection, e.g. detecting unique waveforms indicative of a medical condition (cough events A61B5/0823; seizures A61B5/4094; sleep apnoea A61B5/4818) · CPC title